EyePoint, Inc. (EYPT) by event type
EYPT moves most on analyst downgrades — a median of +6.70% at 30 minutes across 17 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the EYPT overview →
How EYPT reacts across 5 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst downgrades 2 of 2,603 | 17 | +6.70% | 77% | +15.64% |
| Coverage initiations 2,117 of 2,283 | 26 | -1.04% | 39% | +0.31% |
| Rating reiterations 99 of 3,522 | 62 | +0.66% | 66% | +0.23% |
| Price-target raises 1,681 of 1,790 | 11 | -0.35% | 36% | -1.67% |
| Price-target cuts 47 of 1,527 | 15 | +0.51% | 67% | +1.96% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 1 further class was observed with fewer than 10 measured events and is not published.
That’s how EYPT usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst downgrades → · Coverage initiations → · Rating reiterations → · Price-target raises → · Price-target cuts → · EYPT overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Catalyst Pharmaceuticals, Inc. (CPRX) | 441 | 0.00% | 50% |
| Pacific Biosciences of California, Inc. (PACB) | 440 | -0.29% | 44% |
| Abeona Therapeutics Inc. (ABEO) | 438 | +0.09% | 51% |
| KalVista Pharmaceuticals, Inc. (KALV) | 438 | 0.00% | 50% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.